-
FDA Approves Claritin For OTC Use For Seasonal Rhinitis; Simpler Atrial Fibrillation Management; Oral Anticoagulation Vs Aspirin in AF; Immunization Does Not Cause Autism; Statins May Lower CRP Levels; Simvastatin Reduced CRP Plasma Levels; FDA Actions
-
Effects of Losartan on Cardiovascular Morbidity and Mortality in
Patients with Isolated Systolic Hypertension and LVH; Increase in
Nocturnal Blood Pressure and Progression to Microalbuminuria in Type 1
Diabetes; HRT, Lipid, and Glucose Metabolism in Diabetic and
Nondiabetic Postmenopausal Women; Effects of Long-Term Treatment With
ACE Inhibitors in the Presence or Absence of Aspirin; Long-Term Risks
Associated with Atrial Fibrillation: 20-Year Follow-up of the
Renfrew/Paisley Study; Olfactory Impairment in Older Adults
-
Nardino RJ. Chitosan for weight loss and cholesterol lowering. Altern Med Alert 2003;6(1):5-8.
-
Ramalanjaona G. Ginkgo biloba for memory enhancement: An update. Altern Med Alert 2003;6(1):1-5.
-
O'Mathuna DP. Anabolic-androgenic steroids for athletes: Adverse effects. Altern Med Alert 2003;6(1):8-11.
-
La Puma J. Coenzyme Q10 and Parkinson's disease. Altern Med Alert 2003;6(1):12.
-
Whether they want to lose a few pounds that were added over the holidays or develop a more comprehensive weight-loss goal, many of your patients will resolve to lose weight in the new year.
-
The 12-month results of CREDO (clopidogrel for the Reduction of Events During Observation) were presented at AHA to coincide with the publication of this important clinical trial in the November 20, 2002, issue of JAMA.
-
After years of legal wrangling, the FDA has approved loratadine (Claritin, Schering-Plough) as an over-the-counter (OTC) product for the treatment of seasonal rhinitis.
-
Carotid artery stenting is an attractive concept for the treatment of patients with significant carotid stenoses who were at higher risk for carotid endarterectomy, but stroke rates in initial studies were unacceptably high.
